1. Home
  2. Grants
  3. Find Grant Funding
  4. Hereditary Hemorrhagic Telangiectasia (HHT) Center

Hereditary Hemorrhagic Telangiectasia (HHT) Center

About the program

Funding Opportunity Number: HRSA-22-145
Dates to Apply: 03/18/2022 to 05/17/2022
Bureau/Office: Maternal & Child Health Bureau
Status: Closed
Estimated Award Date: 09/30/2022
The Health Resources and Services Administration (HRSA) is accepting applications for the fiscal year (FY) 2022 Hereditary Hemorrhagic Telangiectasia (HHT) Center. The purpose of the program is to reduce morbidity and mortality associated with hereditary hemorrhagic telangiectasia by funding a national center to: 1) expand access to and coordination of care for HHT patients; and 2) develop a de-identified, aggregate data collection registry to better understand this rare disease and treatment outcomes.

Who can apply

Any domestic public or private entity, including an Indian tribe or tribal organization (as those terms are defined at 25 U.S.C. 5304 (formerly cited as 25 U.S.C. 450b)) is eligible to apply. See 42 CFR § 51a.3(a)). Domestic faith-based and community-based organizations are eligible to apply.

Contact us

Cristina Novoa, Ph.D.
(301) 443-1463

Grants toolbox

Contact us

Contact HRSA
(TTY: 877-897-9910)
M - F | 8 a.m. - 8 p.m.
(except holidays)

Call 800-518-4726
Email support

Report fraud
Submit a Complaint
Call: 1-800-HHS TIPS
(TTY: 1-800-377-4950)